To view this video, please enable marketing cookies from Cookie Preferences in the footer.
In this lecture from This is Why, Dr. Busti will explain how Long-Acting Beta Agonists (LABAs) work, where they fit in therapy for the management of asthma and COPD.
You’ll learn how to:
- Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation)
- Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS)
- Onset/duration differences and practical inhaler considerations
- Adverse effects & warnings: tachycardia, tremor, hypokalemia, paradoxical bronchospasm, and key safety concepts
- Therapeutic combos: ICS/LABA combination inhalers and where they fit (including common guideline concepts)
LABA drugs discussed for SEO/review:
- Salmeterol
- Formoterol
- Vilanterol
- Olodaterol
- Indacaterol
The goal = make medical education easy and clinically relevant.
Chapter Table of Contents
00:00 - Introduction to Long-Acting Beta Agonists
01:55 - Agents
02:56 - Indications & Uses
09:08 - Net Benefit
10:44 - Pharmacology
25:02 - Clinical Knowledge
34:30 - Summary
If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
#LABA #LongActingBetaAgonist #Asthma #Bronchodilators #busti
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.
More than just access—it’s where understanding deepens.
Create a free account or log in to gain access to this content!
Related Topics
